Lefamulin (Xenleta) for Community-Acquired Bacterial Pneumonia

This Medical Letter review summarizes the indications, adverse effects, and drug interactions of Lefamulin, a semisynthetic pleuromutilin antibiotic approved by the US Food and Drug Administration for intravenous and oral treatment of community-acquired bacterial pneumonia in adults.
Source: JAMA - Category: General Medicine Source Type: research